KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$6.7 million.

  • Cme's Deferred Taxes rose 945.95% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$71.9 million, marking a year-over-year decrease of 112.52%. This contributed to the annual value of -$66.4 million for FY2024, which is 1146.67% up from last year.
  • As of Q3 2025, Cme's Deferred Taxes stood at -$6.7 million, which was up 945.95% from -$13.3 million recorded in Q2 2025.
  • Cme's 5-year Deferred Taxes high stood at $27.0 million for Q2 2021, and its period low was -$49.2 million during Q4 2023.
  • In the last 5 years, Cme's Deferred Taxes had a median value of -$7.4 million in 2024 and averaged -$8.3 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first surged by 31774.19% in 2021, then crashed by 437272.73% in 2023.
  • Cme's Deferred Taxes (Quarter) stood at $21.0 million in 2021, then plummeted by 105.24% to -$1.1 million in 2022, then plummeted by 4372.73% to -$49.2 million in 2023, then rose by 9.55% to -$44.5 million in 2024, then surged by 84.94% to -$6.7 million in 2025.
  • Its last three reported values are -$6.7 million in Q3 2025, -$13.3 million for Q2 2025, and -$7.4 million during Q1 2025.